Evidence map›Paper›PMID 25704759›Full record

ArticleExperimental cell research2015

Assessing the osteoblast transcriptome in a model of enhanced bone formation due to constitutive Gs-G protein signaling in osteoblasts.

Lalita Wattanachanya, Liping Wang, Susan M Millard, Wei-Dar Lu, Dylan O'Carroll, Edward C Hsiao, Bruce R Conklin, Robert A Nissenson

Abstract read
In one paragraph

Article in Experimental cell research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Conditional Loss of Nmp4 in Mesenchymal Stem Progenitor Cells Enhances PTH-Induced Bone Formation.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2023
    Article
  7. Article
  8. Article
  9. Gs/Gi Regulation of Bone Cell Differentiation: Review and Insights from Engineered Receptors.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Lalita WattanachanyaEndocrine Research Unit, Veterans Affairs Medical Center and Departments of Medicine and Physiology, University of California, San Francisco, CA, USA; Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand. Electronic address: lalita_md@yahoo.com.
Liping WangEndocrine Research Unit, Veterans Affairs Medical Center and Departments of Medicine and Physiology, University of California, San Francisco, CA, USA. Electronic address: lipingwang05@yahoo.com.
Susan M MillardEndocrine Research Unit, Veterans Affairs Medical Center and Departments of Medicine and Physiology, University of California, San Francisco, CA, USA. Electronic address: susan.millard@mater.uq.edu.au.
Wei-Dar LuEndocrine Research Unit, Veterans Affairs Medical Center and Departments of Medicine and Physiology, University of California, San Francisco, CA, USA. Electronic address: weidar_lu@yahoo.com.
Dylan O'CarrollEndocrine Research Unit, Veterans Affairs Medical Center and Departments of Medicine and Physiology, University of California, San Francisco, CA, USA. Electronic address: dylancocarroll@gmail.com.
Edward C HsiaoDivision of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, CA, USA. Electronic address: Edward.Hsiao@ucsf.edu.
Bruce R ConklinGladstone Institute of Cardiovascular Disease, San Francisco, CA, USA; Department of Medicine, University of California, San Francisco, CA, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA. Electronic address: bconklin@gladstone.ucsf.edu.
Robert A NissensonEndocrine Research Unit, Veterans Affairs Medical Center and Departments of Medicine and Physiology, University of California, San Francisco, CA, USA. Electronic address: Robert.Nissenson@ucsf.edu.
University of California, San Francisco · USSan Francisco VA Medical Center · USChulalongkorn University · THGladstone Institutes · US

Funding

G PROTEIN SIGNALING IN OSTEOBLASTSR01DK072071 · NIDDK · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI NISSENSON, ROBERT · 2006 to 2009
$1.3M
Regulation of Bone Formation by G-protein SignalingK08AR056299 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HSIAO, EDWARD C · 2009 to 2013
$640k
G Protein Signaling in OsteoblastsR56DK072071 · NIDDK · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI NISSENSON, ROBERT · 2010 to 2010
$222k
G Protein Signaling in OsteoblastsI01BX001496 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI NISSENSON, ROBERT · 2012 to 2015
–
BLRD VA I01 BX001496NIAMS NIH HHS AR056299NIAMS NIH HHS K08 AR056299NIDDK NIH HHS DK072071NIDDK NIH HHS R01 DK072071NIDDK NIH HHS R56 DK072071
6 · The paper itself

Abstract

G protein-coupled receptor (GPCR) signaling in osteoblasts (OBs) is an important regulator of bone formation. We previously described a mouse model expressing Rs1, an engineered constitutively active Gs-coupled GPCR, under the control of the 2.3 kb Col I promoter. These mice showed a dramatic age-dependent increase in trabecular bone of femurs. Here, we further evaluated the effects of enhanced Gs signaling in OBs on intramembranous bone formation by examining calvariae of 1- and 9-week-old Col1(2.3)/Rs1 mice and characterized the in vivo gene expression specifically occurring in osteoblasts with activated Gs G protein-coupled receptor signaling, at the cellular level rather than in a whole bone. Rs1 calvariae displayed a dramatic increase in bone volume with partial loss of cortical structure. By immunohistochemistry, Osterix was detected in cells throughout the inter-trabecular space while Osteocalcin was expressed predominantly in cells along bone surfaces, suggesting the role of paracrine mediators secreted from OBs driven by 2.3 kb Col I promoter could influence early OB commitment, differentiation, and/or proliferation. Gene expression analysis of calvarial OBs revealed that genes affected by Rs1 signaling include those encoding proteins important for cell differentiation, cytokines and growth factors, angiogenesis, coagulation, and energy metabolism. The set of Gs-GPCRs and other GPCRs that may contribute to the observed skeletal phenotype and candidate paracrine mediators of the effect of Gs signaling in OBs were also determined. Our results identify novel detailed in vivo cellular changes of the anabolic response of the skeleton to Gs signaling in mature OBs.

Indexed as

TranscriptomeAnimalsBone RegenerationCells, CulturedFibroblast Growth Factor 9GTP-Binding Protein alpha Subunits, GsMice, TransgenicOligonucleotide Array Sequence AnalysisOsteoblastsOsteogenesisReceptors, G-Protein-CoupledSignal TransductionSkullSp7 Transcription FactorTranscription FactorsFgf9 protein, mouseFibroblast Growth Factor 9GTP-Binding Protein alpha Subunits, GsReceptors, G-Protein-CoupledSp7 protein, mouseSp7 Transcription FactorTranscription FactorsGene expression analysisG protein coupled receptor (GPCR)Intramembranous boneMouse modelOsteoblasts (OBs)Paracrine mediators

Identifiers

PMID25704759
PMCPMC4408231
OpenAlexW2032760619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.